2.1 KiB
2.1 KiB
Standard Operating Procedure: [Title]
| Document ID | SOP-XXX |
|---|---|
| Title | [Title] |
| Revision | 1.0 |
| Effective Date | [DATE] |
| Author | [AUTHOR] |
| Approved By | [APPROVER] |
| Department | Genetics & Genomics Laboratory |
1. Purpose
[State the purpose of this procedure]
2. Scope
[Define the scope and applicability - e.g., germline testing, somatic testing, specific genes/panels]
3. Responsibilities
3.1 Laboratory Director
- [Responsibility]
- [Responsibility]
3.2 Clinical Molecular Geneticist
- [Responsibility]
- [Responsibility]
3.3 Genetic Counselor
- [Responsibility]
- [Responsibility]
3.4 Bioinformatician
- [Responsibility]
- [Responsibility]
3.5 Laboratory Technologist
- [Responsibility]
- [Responsibility]
4. Definitions
| Term | Definition |
|---|---|
| ACMG | American College of Medical Genetics and Genomics |
| AMP | Association for Molecular Pathology |
| VAF | Variant Allele Frequency |
| VUS | Variant of Uncertain Significance |
| NGS | Next-Generation Sequencing |
| SNV | Single Nucleotide Variant |
| CNV | Copy Number Variant |
| [Term] | [Definition] |
5. Procedure
5.1 [Section Title]
[Procedure steps]
5.2 [Section Title]
[Procedure steps]
6. Quality Control
- [QC checkpoints]
- [Acceptance criteria]
- [Monitoring procedures]
7. Related Documents
- [List related procedures, forms, etc.]
- Example: SOP-VI-001: ACMG/AMP Variant Classification
- Example: FRM-VC-001: Variant Classification Worksheet
8. References
Regulatory References
- CAP Molecular Pathology Checklist
- CLIA regulations for high-complexity testing
- [Applicable state regulations]
Professional Guidelines
- ACMG/AMP Standards and Guidelines for the Interpretation of Sequence Variants (2015)
- ACMG Secondary Findings Recommendations (SF v3.2)
- [Other applicable guidelines]
Scientific Literature
- [Key publications]
- [Evidence base]
Revision History
| Rev | Date | Description | Author |
|---|---|---|---|
| 1.0 | [DATE] | Initial release | [AUTHOR] |